Inside the Oxford AstraZeneca vaccine creation, where Dame Sarah Gilbert and OBE Catherine Green raced against a pandemic. Praised by Chris Evans as "page-turning," this bestseller debunks anti-vax myths while revealing the human story behind science's most urgent mission.
Sarah Gilbert is the author of Vaxxers and a renowned vaccinologist whose groundbreaking work in pandemic response has shaped global public health. A Professor of Vaccinology at the University of Oxford and co-founder of Vaccitech, Gilbert combines decades of expertise in viral immunology with real-world crisis leadership.
Her career highlights include spearheading the development of the Oxford–AstraZeneca COVID-19 vaccine, which was approved in late 2020 and deployed to over 3 billion people worldwide. Gilbert’s research focuses on vaccine design against emerging pathogens, particularly influenza and novel coronaviruses, blending academic rigor with humanitarian urgency.
She has been recognized with prestigious honors such as the Albert Medal (2021) and Princess of Asturias Award (2021), cementing her status as a leading voice in scientific innovation. Vaxxers merges memoir with scientific insight, offering an authoritative firsthand account of vaccine development during a pandemic.
The book has been celebrated for its accessible yet rigorous exploration of medical ethics, global collaboration, and the societal impacts of rapid scientific advancement. Gilbert’s work continues to influence public health policy and inspire future generations of researchers.
Vaxxers chronicles the urgent development of the Oxford-AstraZeneca COVID-19 vaccine, co-authored by vaccinologists Sarah Gilbert and Catherine Green. It combines firsthand accounts of scientific breakthroughs, logistical hurdles, and personal challenges faced during the pandemic. The book demystifies vaccine safety protocols and addresses public skepticism, emphasizing transparency in combating misinformation.
This book appeals to readers interested in medical science, pandemic history, or vaccine development. It’s ideal for science enthusiasts seeking insider perspectives on COVID-19 research, educators discussing public health ethics, or anyone curious about rapid scientific innovation under global pressure.
Yes—Vaxxers humanizes vaccine science through candid storytelling, offering clarity on complex virology and debunking myths. Gilbert and Green balance technical details with relatable anecdotes, making it accessible for non-experts while providing rare insights into large-scale medical collaboration.
The team designed the vaccine using viral vector technology (ChAdOx1), adapting prior Ebola and MERS research. They navigated unprecedented timelines, securing regulatory approvals and manufacturing partnerships within months. The book details how preexisting frameworks enabled rapid adaptation to SARS-CoV-2.
Key hurdles included:
Yes—the authors outline clinical trial phases, peer review processes, and real-time data monitoring. They emphasize rigorous safety checks, including independent oversight committees and post-rollout surveillance to detect rare side effects.
Gilbert and Green confront misinformation by transparently explaining vaccine ingredients (e.g., adenovirus vectors, spike proteins) and dismissing conspiracy theories. They share personal encounters with skeptics, advocating for empathy in public communication.
Anecdotes include:
Unlike journalistic accounts (e.g., The First Shots), Vaxxers provides a scientist’s-eye view of vaccine creation. It avoids political narratives, focusing instead on technical and ethical decisions behind a single vaccine’s deployment.
Key takeaways:
Some reviewers note the book avoids deeper critiques of pharmaceutical profit models or vaccine nationalism. Others desire more policy analysis alongside its scientific focus, though this falls outside the authors’ firsthand scope.
Gilbert and Green portray researchers as relatable figures—exhausted yet driven parents, collaborators navigating setbacks, and advocates balancing hope with skepticism. Their narrative counters stereotypes of detached “lab elites”.
著者の声を通じて本を感じる
知識を魅力的で例が豊富な洞察に変換
キーアイデアを瞬時にキャプチャして素早く学習
楽しく魅力的な方法で本を楽しむ
Vaccines aren't discovered like hidden treasure; they're designed.
Academic research careers are unstable.
We're just going to have to do it anyway and work out the money later.
Named by Time magazine as "Heroes of the Year" in 2021.
This wasn't one of shadowy global elites or pharmaceutical profiteering.
『Vaxxers』の核心的なアイデアを分かりやすいポイントに分解し、革新的なチームがどのように創造、協力、成長するかを理解します。
『Vaxxers』を素早い記憶のヒントに凝縮し、率直さ、チームワーク、創造的な回復力の主要原則を強調します。

鮮やかなストーリーテリングを通じて『Vaxxers』を体験し、イノベーションのレッスンを記憶に残り、応用できる瞬間に変えます。
何でも質問し、声を選び、本当にあなたに響く洞察を一緒に作り出しましょう。

"Instead of endless scrolling, I just hit play on BeFreed. It saves me so much time."
"I never knew where to start with nonfiction—BeFreed’s book lists turned into podcasts gave me a clear path."
"Perfect balance between learning and entertainment. Finished ‘Thinking, Fast and Slow’ on my commute this week."
"Crazy how much I learned while walking the dog. BeFreed = small habits → big gains."
"Reading used to feel like a chore. Now it’s just part of my lifestyle."
"Feels effortless compared to reading. I’ve finished 6 books this month already."
"BeFreed turned my guilty doomscrolling into something that feels productive and inspiring."
"BeFreed turned my commute into learning time. 20-min podcasts are perfect for finishing books I never had time for."
"BeFreed replaced my podcast queue. Imagine Spotify for books — that’s it. 🙌"
"It is great for me to learn something from the book without reading it."
"The themed book list podcasts help me connect ideas across authors—like a guided audio journey."
"Makes me feel smarter every time before going to work"

Vaxxersの要約をPDFまたはEPUBで無料でダウンロード。印刷やオフラインでいつでもお読みいただけます。
In January 2020, as most of the world carried on unaware, vaccinology professor Sarah Gilbert noticed disturbing reports about a mysterious pneumonia outbreak in Wuhan, China. This wasn't just another seasonal illness - it bore alarming similarities to SARS, the coronavirus that had infected 8,000 people across 29 countries in 2002-2003 with a 10% mortality rate. Gilbert had spent years preparing for what experts called "Disease X" - an unknown pathogen that could trigger a devastating pandemic. Her team had developed ChAdOx1, a versatile vaccine platform using a modified chimpanzee adenovirus that could be quickly adapted against new threats. When news of the Wuhan outbreak emerged, Gilbert and her colleague Tess Lambe made a critical decision: they would begin vaccine development as soon as the virus's genetic sequence became available. What they couldn't know then was that their work would soon become humanity's greatest hope in the darkest global crisis of our lifetime. Imagine receiving a test tube that appears empty but actually contains 100 billion dehydrated strands of DNA - the blueprint for a vaccine that could end a global pandemic. This was the starting point for Catherine Green's team at Oxford's Clinical Biomanufacturing Facility in late January 2020. Creating a vaccine isn't about discovery - it's about design, precision manufacturing, and rigorous testing. The process resembles artisanal breadmaking: first creating a "starter" by growing cells and introducing the viral vector, then expanding this culture to produce the required quantity, purifying it through specialized filtration, filling sterile vials under precise conditions, and finally testing, certifying and distributing according to strict regulations.